Recent advances in the management of myelofibrosis

Clin Adv Hematol Oncol. 2016 Aug;14(8):597-9.
No abstract available

Publication types

  • Interview

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials as Topic
  • Disease Management
  • Humans
  • Incidence
  • Janus Kinases / antagonists & inhibitors
  • Primary Myelofibrosis / diagnosis*
  • Primary Myelofibrosis / epidemiology
  • Primary Myelofibrosis / etiology
  • Primary Myelofibrosis / therapy*
  • Prognosis
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Research
  • Time-to-Treatment
  • Treatment Outcome

Substances

  • Protein Kinase Inhibitors
  • Janus Kinases